Zhujiang Hospital

This study tests a drug called romiplostim N01 in 60 adults with solid tumors (like lung or breast cancer) who have low platelet counts after radiation combined with other treatments. The goal is to see if the drug safely raises platelet levels within two weeks. It aims to provid…

This study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, doctors want to know which follow-up plan works best: radiation therapy, an immunotherapy drug (PD-1 inhibitor), or just watching and waiting. The…

This early study tests the safety of a nasal spray made from tiny particles (extracellular vesicles) derived from umbilical cord stem cells in 9 people who had an ischemic stroke. The goal is to see if it is safe and if it might help the brain heal. Participants must be between 1…

This early-phase study tests a new treatment for adults with B-cell acute lymphoblastic leukemia or lymphoma who cannot tolerate intensive chemotherapy. Patients receive a single infusion of their own immune cells (CAR-T cells) that have been modified to target cancer cells. The …

This early-stage trial tests whether the drug Racecadotril can help protect organ function in people with sepsis, a life-threatening response to infection. About 44 adults in intensive care will receive either the drug or a placebo, in addition to standard sepsis treatment. The m…

This study tests whether combining two types of brain stimulation (tDCS and rTMS) can improve motor function in people with locked-in syndrome, a condition where the body is paralyzed but the mind is awake. 72 participants will receive either real or sham stimulation for 4 weeks,…

This study tests whether a new intravenous drug called Anrikefon can improve sleep quality better than a standard oral medication (nalfurafine) in people with chronic kidney disease who suffer from severe itching during dialysis. About 50 adults on regular hemodialysis will recei…

This study follows 2,800 Chinese adults aged 18–60 who are overweight or obese, with or without type 2 diabetes, for five years. Researchers will use a digital health platform and AI to track how their metabolic health changes over time, including transitions to diabetes or compl…

This observational study will look at 200 adults—some healthy and some with metabolic fatty liver disease—to see if a specific gut bacterium called Ruminococcus gnavus and its byproducts are linked to the condition. No treatments or interventions are given; the goal is simply to …

This observational study looks at how lactate, a natural substance, changes gut bacteria and how that might be linked to worsening liver cirrhosis. Researchers will compare 200 people with and without liver disease by measuring lactate in blood, stool, and tissue samples. No trea…